4basebio (LSE:4BB) FCF Yield % : -3.61 (As of May. 16, 2024)

View and export this data going back to 2021. Start your Free Trial

What is 4basebio FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, 4basebio's Trailing 12-Month Free Cash Flow is £-6.53 Mil, and Market Cap is £180.55 Mil. Therefore, 4basebio's FCF Yield % for today is -3.61%.

The historical rank and industry rank for 4basebio's FCF Yield % or its related term are showing as below:

LSE:4BB' s FCF Yield % Range Over the Past 10 Years
Min: -10.79 Med: -6.28 Max: -2
Current: -3.61

During the past 4 years, the highest FCF Yield % of 4basebio was -2.00%. The lowest was -10.79%. And the median was -6.28%.

LSE:4BB's FCF Yield % is ranked better than
75% of 1556 companies
in the Biotechnology industry
Industry Median: -14.305 vs LSE:4BB: -3.61

4basebio's FCF Margin % for the quarter that ended in Jun. 2023 was -1,564.29%.

4basebio FCF Yield % Historical Data

The historical data trend for 4basebio's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio FCF Yield % Chart

4basebio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

FCF Yield %

-5.61

-7.60

4basebio Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Yield %	Get a 7-Day Free Trial			-7.24	-5.85	-14.67	-6.41	-10.51

Competitive Comparison of 4basebio's FCF Yield %

For the Biotechnology subindustry, 4basebio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4basebio's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4basebio's FCF Yield % distribution charts can be found below:

* The bar in red indicates where 4basebio's FCF Yield % falls into.

4basebio FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

4basebio's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-6.645	/	87.45425
	=	-7.60%

4basebio's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-3.723	*	2	/	70.837125
	=	-10.51%

4basebio FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

4basebio FCF Yield % Related Terms

Thank you for viewing the detailed overview of 4basebio's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (LSE:4BB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

88Q:Germany

Address

25 Norman Way, Over, Cambridge, GBR, CB24 5QE

Website

https://www.4basebio.com

4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (LSE:4BB) Headlines

No Headlines